Iran is experiencing a severe medication inflation crisis, with drug prices soaring by 100-600% in recent months due to government mismanagement and halted foreign exchange subsidies. Many retirees and workers can no longer afford essential medicines, leading to increased reliance on counterfeit drugs and treatment abandonment. Vulnerable populations, particularly the elderly, are disproportionately affected, with chronic illnesses becoming life-threatening. The healthcare system’s inadequacies violate constitutional guarantees of free medical care, while the regime prioritizes military and foreign interests over public health. As access to medications becomes a privilege for the wealthy, a healthcare catastrophe threatens the nation’s stability and moral fabric.